Wednesday, July 8, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Patents matching “The United States of America, as represented by the Secretary, Department of Health”

1,166 pharma patents match "The United States of America, as represented by the Secretary, Department of Health" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 1,166
Index total 30,257
Page 23 / 49

Quick answer

This filtered view shows 1,166 pharmaceutical patents matching "The United States of America, as represented by the Secretary, Department of Health" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

1,166 results for “The United States of America, as represented by the Secretary, Department of Health” · 30,257 patents in full index Clear search

  1. US 10301314

    Compounds and methods for the prevention and treatment of tumor metastasis and tumorigenesis

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted May 28, 2019 · Expires May 23, 2039

    granted

  2. US 10300115

    Methods and compositions for modulating immune tolerance

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted May 28, 2019 · Expires May 23, 2039

    granted

  3. US 10301621

    Multifunctional RNA nanoparticles and methods of use

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted May 28, 2019 · Expires May 23, 2039

    granted

  4. US 10293005

    Use of gram negative species to treat atopic dermatitis

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted May 21, 2019 · Expires May 16, 2039

    granted

  5. US 10287350

    Chimeric antigen receptors targeting CD-19

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted May 14, 2019 · Expires May 9, 2039

    granted

  6. US 10287340

    Anti-HIV domain antibodies and method of making and using same

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted May 14, 2019 · Expires May 9, 2039

    granted

  7. US 10286050

    Multi-epitope TARP peptide vaccine and uses thereof

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted May 14, 2019 · Expires May 9, 2039

    granted

  8. US 10287297

    Epoxyazulene derivatives useful for treating cancer and diabetes

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted May 14, 2019 · Expires May 9, 2039

    granted

  9. US 10287279

    Inhibitors of human 12/15-lipoxygenase

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted May 14, 2019 · Expires May 9, 2039

    granted

  10. US 10281475

    Systems and methods to identify and treat subjects at risk for obstetrical complications

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted May 7, 2019 · Expires May 2, 2039

    granted

  11. US 10280307

    Class of stable heptamethine cyanine fluorophores and biomedical applications thereof

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted May 7, 2019 · Expires May 2, 2039

    granted

  12. US 10273299

    Antibodies to tumor endothelial marker 8

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Apr 30, 2019 · Expires Apr 25, 2039

    granted

  13. US 10273291

    Focused evolution of HIV-1 neutralizing antibodies revealed by crystal structures and deep sequencing

    THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES, OFFICE OF TECHNOLOGY TRANSFER—NATIONAL INSTITUTES OF HEALTH · Granted Apr 30, 2019 · Expires Apr 25, 2039

    granted

  14. US 10273288

    Neutralizing antibodies to Ebola virus glycoprotein and their use

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Apr 30, 2019 · Expires Apr 25, 2039

    granted

  15. US 10272039

    Topical sodium nitrite formulation

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Apr 30, 2019 · Expires Apr 25, 2039

    granted

  16. US 10266565

    Peptide mimetic ligands of polo-like kinase 1 polo box domain and methods of use

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Apr 23, 2019 · Expires Apr 18, 2039

    granted

  17. US 10265382

    Complexes of IL-15 and IL-15Ralpha and uses thereof

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Apr 23, 2019 · Expires Apr 18, 2039

    granted

  18. US 10265313

    Plasmodial surface anion channel inhibitors for the treatment or prevention of malaria

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Apr 23, 2019 · Expires Apr 18, 2039

    granted

  19. US 10258701

    Labeled evans blue dye derivative for in vivo serum albumin labeling

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Apr 16, 2019 · Expires Apr 11, 2039

    granted

  20. US 10258682

    Attenuated chlamydia vaccine

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Apr 16, 2019 · Expires Apr 11, 2039

    granted

  21. US 10251912

    MHC class II restricted T cell epitopes from the cancer antigen, NY ESO-1

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Apr 9, 2019 · Expires Apr 4, 2039

    granted

  22. US 10246463

    Hypoxia-inducible factor 1 (HIF-1) inhibitors

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Apr 2, 2019 · Expires Mar 28, 2039

    granted

  23. US 10246505

    Chimeric antigen receptors to control HIV infection

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Apr 2, 2019 · Expires Mar 28, 2039

    granted

  24. US 10233209

    Inhibitors of the farnesoid x receptor and uses in medicine

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Mar 19, 2019 · Expires Mar 14, 2039

    granted

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.